Description
An ATP-competitive inhibitor of Hsp90 that causes degradation of client proteins, resulting in cell cycle arrest or apoptosis; orally bioavailable and shows efficacy in tumor regression in gastric carcinoma and melanoma xenografts in mice
Formal name: N1-[(3-endo)-8-[5-(cyclopropylcarbonyl)-2-pyridinyl]-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-5-[[(1R)-1-methylpropyl]amino]-1,4-benzenedicarboxamide
Synonyms:
Molecular weight: 503.6
CAS: 1149705-71-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Heat Shock Proteins||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Cell Biology|Cellular Chaperones